SecBot SecBot

ORMP

ORAMED PHARMACEUTICALS INC.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001176309 Biotech & Drug Discovery
$3.90 +0.19 (+5.12%)
Nov 16 4:00 PM ET · prev $3.71
Market cap
$175.2M
Micro cap
Median target
$7.00
+79% · range $7.00–7.00
1 year
+66.7%
from $2.34 · Nov 17
30 days
−3.9%
from $4.06
52-week range
$2.34–5.34
−27% from high · low Nov 17
Avg volume 20D
121.9K
Nov 16 spike 346.6K
Short interest
1.34M
≈3.2% of shares · −7.4%
Days to cover
11.3
at average volume
Insider net
−$1.2M
0 buyers · 2 sellers · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
4
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 1/2

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

  • Jul 1 ▼ 2 insiders sell $942.2K at $4.48
  • Oct 1 ▼ 2 insiders sell $225.5K at $4.51

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders sold $1.2M.

  • InstitutionsBULLISH

    Q3 2026: 14 added (0 new), 5 trimmed or exited.

  • Short sellersSTEADY

    Short interest −7.4% to 1.34M shares. 11.3 days to cover, ≈3.2% of shares.

  • TrendDOWNTREND

    10% below its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
STATE STREET CORPADD466,720$2.2M
RENAISSANCE TECHNOLOGIES LLCADD294,268$1.4M
STRS OHIOADD188,500$880.3K
MORGAN STANLEYDOUBLED107,987$504.3K
UBS Group AGADD97,523$455.4K
O'SHAUGHNESSY ASSET MANAGEMENT, LLCTRIM75,772$312.9K
Connor, Clark & Lunn Investment Management Ltd.DOUBLED52,823$246.7K
JANE STREET GROUP, LLCNEAR_EXIT27,068$126.4K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Sep 2024
12-month targets · 1 analysts

Price is below the lowest target. Median implies +79%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Sep 9, 2024HC Wainwright & Co.
REITERATE
REITERATENeutral
May 20, 2024HC Wainwright & Co.
REITERATE
REITERATENeutral
May 17, 2023Canaccord Genuity
MAINTAIN
MAINTAINHold
Jan 17, 2023HC Wainwright & Co.
DOWNGRADE
DOWNGRADENeutral
Jan 12, 2023Canaccord Genuity
DOWNGRADE
DOWNGRADEHold
May 16, 2022Aegis Capital
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$1.2M
sold · 2 insiders
DateInsiderTypeValue
Nov 12, 2026
Kidron Miriam
Chief Scientific Officer
Nov 12, 2026
AWARD242,000 sh
Nov 12, 2026
Aghion Daniel
Director
Nov 12, 2026
AWARD72,780 sh
Nov 12, 2026
Kidron Miriam
Chief Scientific Officer
Nov 12, 2026
AWARD357,000 sh
Nov 12, 2026
Gabay Avraham
Chief Financial Officer
Nov 12, 2026
AWARD357,000 sh
Nov 12, 2026
Gabay Avraham
Chief Financial Officer
Nov 12, 2026
AWARD242,000 sh
Nov 12, 2026
Hexter Joshua
COO & CBO
Nov 12, 2026
AWARD357,000 sh
Nov 12, 2026
Hexter Joshua
COO & CBO
Nov 12, 2026
AWARD242,000 sh
Nov 12, 2026
KIDRON NADAV
President and CEO
Nov 12, 2026
AWARD629,000 sh

Earnings setup

Estimates
$0.37
EPS estimate, this quarter
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.37$0.37–$0.37-19.6%$0.00
Next QNoneNoneNo data$0.00
Current FY$4.47$4.47–$4.47+93.5%$0.00
Next FYNoneNoneNo data$0.00

Short side

FINRA· Oct 30, 2026
1,343,457
shares short
-7.4%
vs prior settlement
11.3
days to cover
≈3.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 13, 2026 SEC
Aquamarine Financial (Cayman) Ltd filed an amended Schedule 13G disclosing a 6.38% passive stake in Oramed…
SC 13G/A · Impact 3/10
Nov 12, 2026 Insider
Kidron Miriam was granted 242,000 shares
Chief Scientific Officer
Nov 12, 2026 Insider
Aghion Daniel was granted 72,780 shares
Director
Nov 12, 2026 Insider
Kidron Miriam was granted 357,000 shares
Chief Scientific Officer
Nov 11, 2026 Earnings calendar
ORMP Q3 2026 Earnings Scheduled · 2026-11-11
Oct 2, 2026 SEC
Two C-suite insiders at Oramed Pharmaceuticals sold a combined $226K in open-market sales on the same day, with no…
CLUSTER · Impact 3/10
Sep 30, 2026 Inst.
STATE STREET CORP · ADD
466,720 shares ($2.2M)
Sep 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC · ADD
294,268 shares ($1.4M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

4 filings · 0 bullish · 0 bearish · 1 mixed · 3 neutral
All ORMP filing & press-release reports (4)